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SUMMARY.-Thirty-five cases of primary reticulum-cell sarcoma seen
during 28 years are presented.
These tumours occurred five times more frequently in males than in females,
and were seen most commonly in adults. The femur was the commonest
location. None of the tumours was located in the small bones of the hand, foot
or skull bones (excluding maxilla).
Radiation therapy has been the treatment of choice. Though the initial
response was good, local recurrence and metastasis to regional nodes and
generalised dissemination was not uncommon. Radiation therapy to regional
nodes and concomitant chemotherapy are suggested to prevent metastasis in
regional nodes and generalised dissemination.
These tumours were found to have a spectrum of activity varying from a
rapid fatal outcome within a few months to survival for many years.
PRIMARY reticulum-cell sarcoma of the bone as a distinct type of malignant
bone tumour has been recognised only recently. It was first suggested by
Oberling in 1928. Ewing in 1939 accepted it as a distinctly separate type of
bone tumour in the revised classification of bone tumours for the Bone Sarcoma
Registry of the American College of Surgeons, and Parker and Jackson in the
same year reported in detail the clinico-pathological features of this tumour.
Since then, few reports of large series have appeared in the literature, the notable
ones being those of Coley and his associates (Coley, Higinbotham and Groesbeck,
1950) from the Memorial Hospital, New York, and of McCormack and his co-
workers (McCormack, Ivins, Dahlin and Johnson, 1952; Ivins and Dahlin, 1953,
1963) from the Mayo Clinic.
Bone may be affected by reticulum-cell sarcoma in two ways. Primary,
when there is no sign of the disease elsewhere except in the affected bone, or
secondarily, as metastasis or direct spread from reticulum-cell sarcoma ofregional
or distant lymph nodes or of any other organs. Primary reticulum-cell sarcoma
of bone has a significantly different clinical course from reticulum-cell sarcoma
secondarily affecting bone. Coley et al. (1950) have laid down the following
criteria for the inclusion of a tumour as primary reticulum-cell sarcoma. They
are: (a) clinically a primary focus in a single bone, (b) unequivocal histological
proof from the bone lesion (not from a metastasis), (c) metastasis present at the
time offirst visit only ifregional or ifthe onset ofsymptoms ofthe primary tumour
preceded the appearance of metastasis by at least 6 months.
Coley et al. (1950) found primary reticulum-cell sarcoma to constitute 5.300
(58 out of 1091) of malignant bone tumours. Ivins and Dahlin found primaryRETICULUM-CELL SARCOMA OF BONE
reticulum-cell sarcoma to constitute 2*5% of all bone tumours (49 out of 2000
tumours). B-orges, Paymaster and Bhansali (1967) have reported the series of
primary malignant bone tumour from the Tata Memorial Hospital, Bombay; they
found primary reticulum-cell sarcoma to constitute 6% of all malignant bone
tumours. Secondary involvement of bone by reticulum-cell sarcoma is more
frequent than primary reticulum-cell sarcoma of bone. Coles and Schulz (1948)
have reported an incidence of 32% bone involvement in a series of 58 cases of
reticulum-cell sarcoma.
The purpose of this paper is to report our experience regarding the clinical
features, radiological appearances and biological behaviour of primary reticulum-
cell sarcomas of the bone.
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Fic. 1.-Age distribution of primary reticulum-cell sarcoma, of bone.
MATERIAL
Thirty-five cases ofreticulum-cell sarcoma ofthe bone were seen in the Depart-
ment of Surgery of the Tata Memorial Hospital, Bombay, during the period of
28 years from 1941 through 1968. Material was available for histological examina-
tion in all the cases and only those cases which confirmed the criteria laid down by
Coley et al. (1950), and listed above, are included in this series.
Age and sex distribution
The youngest patient in this series was 9 years old and the oldest 71 years old,
with an average of 37 8 years. As seen in Fig. 1, these tumours occurred more
commonly in the third, fourth and fifth decades.
In this series these tumours occurred five times more frequently in males than
in females (29 males and 6 females).
History of trauma
There was a history of trauma two weeks to a few years before the onset of
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TABLE I.-Location8 ofPrimary Reticulum-cell Sarcoma ofBone
Number
Site of cases
Maxilla. . . 3
Mandible . . 3
Clavicle . . 2
Scapula . . . 3
Humerus . . . 1
Spine . . . . 1
Sternum . . . 3
Ribs . . . . 3
Pelvis . . . . 6
Femur . . 9
Tibia . . . . 1
Total . . . 35
MAXILLA 3
\a¢/ ~MANDIBLE 3
CLAVICLE 2SCPL3
STERNUM 3
RIBS 3 SPINIA LU
0 ~~~UPPER END 3
(~~) : ~~SHAFT 2
LOWER END 4
FIa. 2.-Location ofprimary reticulum-cell sarcoma of bone.RETICULUM-CELL SARCOMA OF BONE
symptoms in 8 cases while trauma was denied in 7 cases. In the remaining cases
there was no mention of injury.
Location
The tumours occurred most frequently in the femur and the innominate bone.
Next infrequency were flat bones like theribs, sternum, scapula andthejaw bones,
while they were practically never noted in distal long bones, small bones of the
foot and hand or skull bones-excluding maxilla (Table I and Fig. 2).
This distribution differs from that reported by several other authors. Coley
et al. (1950) from the Memorial Hospital and McCormack et al. (1952) from the
Mayo Clinic noticed large numbers of tumours originating from the tibia and
humerus whereas in this series only two tumours were located in these bones.
Sherman and Snyder (1947) found in their series, and in that reported by Parker
and Jackson (1939), that 40% of tumours were located around the knee, but in
this series only 5 cases, i.e. about 14%, were found in these sites.
Locations of primary reticulum-cell sarcoma are different from reticulum-cell
sarcoma secondarily involving the bone. The spine and skull bones are rarely
affected by primary reticulum-cell sarcoma, whereas these bones are affected
frequently by secondary tumours ofthis type.
Symptoms and signs
The duration of symptoms varied from 6 weeks to 3 years with an average of
6-4 months. Eighty per cent of cases were seen within one year of onset of
symptoms.
Swelling was present at the time of first reporting to the hospital in all except
4 cases. The size of the swellings varied considerably, from 2 cm. to 20 cm. in
diameter. The consistency varied, depending upon soft tissue involvement.
In those cases with marked soft tissue spread the consistency was firm or soft and
cystic. In those where the tumour was mainly endosteal, the consistency was
bony hard. Tenderness was noticed in one-third of cases. Local increase in heat
and dilated veins were noted in only 4 cases.
Pain was complained ofbytwo-thirds ofthe patients, but the form and severity
varied considerably. It was the initial symptom preceding the appearance of
swelling in 8 cases. Fever was present in 2 cases; one of them had a discharging
sinus.
Eight patients, at the time of admission or during the course of the disease,
developed enlarged regional nodes which were firm or rubbery in consistency, and
not tender. Four patients developed distant lymph node metastasis, 2 developed
an enlarged spleen, but none had a clinically enlarged liver.
Metastases in other bones were noticed during the course of disease in 6 cases.
Skull bones, spine and ribs were each involved in 2 cases while the femur and
humerus were affected once. Pulmonary metastasis was noticed in 3 cases. In
one there was an associated haemorrhagic pleural effusion.
Laboratory investigations were done in only two-thirds of the cases. In all
ofthem serum phosphorus and alkaline and acid phosphatases were within normal
limits. The only significant findings noted were raised serum calcium above
11 mg./100 ml. in 4 cases, anaemia in 7 and increased erythrocyte sedimentation
rate in 5.
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Radiological appearance
Radiological appearances varied considerably but usually they showed as
mottled osteolytic destruction of the bone with minimum new bone formation.
The process is usually seen to start in the medullary portion ofthe bone, extending
more endosteally than periosteally. In the long bones the disease was frequently
found to have spread along the long axis of the bone as seen in Fig. 3 and 4.
Pathological fracture was noticed in 5 instances (Fig. 5). Periosteal reaction was
not a prominent feature; it occurred in only a few cases and was mainly oflamellar
type. The perpendicular type of periosteal reaction was never seen. In a few
cases the osteolytic process was so marked that a portion of the bone was com-
pletely washed out, as seen in Fig. 6. Soft tissue shadows were seen in many cases
but in none of them was it a prominent feature. As also noticed by Sherman
and Snyder (1947), calcification in soft tissue was never seen in this series.
Sherman and Snyder (1947) have described the radiological appearances of
primary reticulum-cell sarcoma in detail. They found significant similarity in
many cases and claim that the appearances are sufficiently characteristic to
suggest the diagnosis. But in this series reticulum-cell sarcoma was diagnosed on
radiological appearances in only 5 cases.
The diagnosis ofprimary reticulum-cell sarcoma is often impossible on clinical
examination and radiological investigation alone, and bone biopsy is therefore
necessary for confirming the diagnosis. Aspiration biopsy is often performed in
this Institute for diagnostic purposes, and in this series it was helpful in establish-
ing the diagnosis in 6 cases. In the remaining cases open bone biopsy was
necessary.
Pathology
Macroscopic appearance. Material for gross examination was available in
only a few cases. The tumour tissue appeared homogeneous and greyish-white
or greyish-pink in colour, with areas of haemorrhage and necrosis in some cases.
The tumour tissue was usually soft and friable. The cut surface ofthe specimens
showed the tumour tissue extending along the marrow cavity as well as destroying
the cortex and in some cases perforating the cortex and involving the soft tissues
(Fig. 8).
Microscopic appearances. The microscopic pattern varied in various tumours
but did not differ much from the microscopic appearance ofreticulum-cell sarcomas
of soft tissues. The main component of the tumours, the reticulum cells, varied
EXPLANATION OF PLATES
FIG. 3.-Reticulum-cell sarcoma of humerus. Note the mottled osteolytic destruction.
FIG. 4(a) and 4(b).-Reticulum-cell sarcoma offemur. Note the endosteal spread and minimal
periosteal reaction.
FIG. 5.-Reticulum-cell sarcoma of scapula. Note the pathological fracture.
FIG. 6. Reticulum-cell sarcoma of upper end of femur. Note the completely washed out
appearance.
FIG. 7(a).-Primary reticulum-cell sarcoma of ilium
FIG. 7(b).-After radiation therapy. Note the calcification and scarred bone.
FIG. 8.-Cut surface of primary reticulum-cell sarcoma of lower end of femur.
FIG. 9. Photomicrograph of reticulum-cell sarcoma.
FIG. 10. Photomicrograph of primary reticulum-cell sarcoma (Gomori's reticulin stain).
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in size and shape. The size varied from twice to four times the size of lympho-
cytes, and the shape varied from round to oval or elongated. The eosinophilic
cytoplasm varied in amount, and in some cells it was seen streaming into the
surrounding tissue. The nuclei varied in shape; they were round, oval, indented
(reniform) or lobulated. Occasional cells contained double nuclei (Fig. 9 and 10).
The cells either did not have any characteristic pattern or were seen in an alveo-
lar arrangement of small groups of cells separated by vascular stroma. Gomori's
reticulin stain showed the fibres surrounding small groups of cells or running
between and encompassing individual cells. For further details readers are
referred to excellent descriptions by Khanolkar (1948) and McCormack et al.
(1952)
Treatment
Nine patients had received treatment elsewhere and were referred here follow-
ing recurrence of disease. Eight patients had conservative excision of their
tumours, and one of them had in addition post-operative radiation therapy.
The remaining case had received radiation and chemotherapy.
Radiation therapy had been the treatment of choice in this series. Dosage
varied from 2600 R to 6000 R total tumour dose and was delivered with 250 kV
machine and as telecobalt therapy. In recent years radiation therapy has often
been combined with chemotherapy, especially for recurrent tumours and for those
patients who had developed metastases in distant sites. The chemotherapeutic
drugs used in this series were cyclophosphadide (Endoxan) in 6 cases and nitrogen
mustard in 2.
Only 2 patients, both with tumours of the femur, had surgery as the primary
treatment. One case had surgery (scapulectomy) for recurrence following radia-
tion therapy.
Four patients did not receive any treatment; 2 refused the treatment offered
to them and the other 2 were seen in a very advanced stage of the disease (Table
II).
TABLE II. Summary of Treatment
Type of treatment No. of cases
Radiation . . . 21
Radiation and chemotherapy 7
Radiation, surgery and chemotherapy . . 1
Surgery . 9
Not treated . . . 4
Total . . 35
Results of treatment and survival
Most of the patients had good regression of the primary lesions and relief of
symptoms after initial radiation therapy. With regression of the tumour the
roentgenograms showed diminution of the soft tissue swelling, recalcification or
sclerosis of bone, regaining of normal contour of bone and healing of pathological
fractures. The metastatic nodes and metastatic lesions in other bones also
showed regression of tumour after radiation therapy. But the ultimate results
were not satisfactory. Following radiation therapy in 6 cases the disease recurred
locally, 5 cases developing metastases in other bones and 6 in lymph nodes.
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In this series chemotherapy was mainly used for recurrent and metastatic
lesions, and in 5 of 7 cases it gave good palliation with regression of swelling and
amelioration of symptoms. However, except for one patient who is still alive
after 1 year and 9 months, all died of the disease.
Nine patients are lost to follow-up. They include 4 untreated cases. Nineteen
patients died of the disease, all of them within 21 years of their first visit to this
hospital. Not one of the cases treated here for recurrent disease following treat-
ment elsewhere has survived. Seven patients are alive and free of disease for
18 years, 14 years, 9 years, and the remainder for less than 5 years.
COMMENT
Primary reticulum-cell sarcoma is a rather uncommon type of primary malig-
nant bone tumour, but there is no doubt ofits being a distinct type ofbone tumour
because of its characteristic histological appearance and biological behaviour.
The diagnosis of it from the clinical and radiological features is often impossible.
Bone biopsy is mandatory before embarking on definitive therapy, as radio-
logically these lesions often resemble metastatic lesions. These tumours have a
significantly different and more favourable clinical course than that of reticulum-
cell sarcoma of soft tissue secondarily involving bone. Coley et al. (1950) have
reported 47-6% five year survival of primary reticulum-cell sarcoma of bone.
McCormack et al. (1952) reported 56% survival with an average interval of 139-5
months from the first treatment to the last time heard from. This is in contrast
to the invariably fatal outcome in secondary reticulum-cell sarcoma of bone.
Craver and Copeland (1934) found the majority of patients dead within one year
of appearance of disease in bone from the group of 17 cases of generalised reticu-
lum-cell sarcoma involving bone. The comparatively poor results of treatment
seen in this series are probably due to a large number of recurrent tumours and
extensive involvement of bones at the initial visits of the patients.
Radiation therapy has been the treatment of choice in this and many other
series. The results of treatment of primary reticulum-cell sarcoma are reported
as being better than those of other primary malignant bone tumours by many
authors. Experience with this series has shown that the tumour often recurs if
the total tumour dosage is less than 3000 R, in contrast to some reports in the
literature of the cure of patients with reticulum-cell sarcoma treated with smaller
doses. To prevent recurrence in a majority of cases, treatment of primary lesions
with large dosage ofradiation and including the whole bone is suggested. Further-
more, as many patients develop metastasis to regional lymph nodes and often
terminate in a generalised form a logical step to improve the results seems to be to
treat the regional nodes, whether clinically involved or not, with radiation therapy
and combine the radiation therapy with chemotherapy to take care of the ten-
dency for generalised dissemination. A diagnosis of primary reticulum-cell
sarcoma of bone according to many authors spells a good prognosis, but this has
not been our experience with this series, nor was it the experience of Dalan (1962).
Primary reticulum-cell sarcomas in this series were found to have a spectrum of
activities ranging from a rather benign course with survival for many years to a
very aggressive growth terminating fatally within a few months of the initial
diagnosis.
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